文献速递心脑血管急症重症综合管理与镇静镇痛

补体激活与院外心脏骤停后不良结局相关

Complement activation is associated with poor outcome after out-of-hospital cardiac arrest.
PubMed 文献 · Resuscitation · 2021-06-11
一句话结论院外心脏骤停患者入院时sC5b-9升高与6个月不良神经结局(含死亡)相关,校正自主循环恢复时间>25分钟后关联不再显著。

该研究纳入232例复苏成功的院外心脏骤停患者,在入院时和第三天检测补体激活产物C3bc、sC5b-9及可溶性CD14,并检测内皮细胞激活标志物syndecan-1、sE-selectin、血栓调节蛋白和血管细胞黏附分子。6个月时49%的患者结局良好(脑功能分类1-2分)。入院时C3bc和sC5b-9显著高于第三天(两者p<0.001),且不良结局组显著高于良好结局组(p=0.03和p<0.001)。未校正时入院sC5b-9与不良结局相关(OR 1.08,95%CI 1.01-1.14,p=0.024);校正后sC5b-9仍与结局相关,但将自主循环恢复时间>25分钟作为协变量纳入后关联不再显著。内皮激活标志物从入院到第三天升高,仅sE-selectin和血栓调节蛋白在不良结局组显著更高(p=0.004和p=0.03)。

要点

  • 232例院外心脏骤停患者中49%在6个月时结局良好(脑功能分类1-2分),不良结局定义为脑功能分类3-5分含死亡。
  • 入院时C3bc和sC5b-9显著高于第三天(两者p<0.001),且不良结局组显著高于良好结局组(p=0.03和p<0.001)。
  • 未校正时入院sC5b-9与不良结局相关(OR 1.08,95%CI 1.01-1.14,p=0.024);校正后仍相关,但纳入自主循环恢复时间>25分钟作为协变量后关联不再显著。
  • 内皮激活标志物从入院到第三天升高,仅sE-selectin和血栓调节蛋白在不良结局组显著更高(p=0.004和p=0.03),分别与sCD14和sC5b-9/C3bc相关。
  • 作者认为入院时sC5b-9反映的补体系统激活并导致后续内皮细胞激活,与院外心脏骤停患者不良结局相关。

适用人群与场景

  • 232例复苏成功的院外心脏骤停患者,6个月时评估结局。

诊断标准与关键阈值

  • 结局定义:6个月时脑功能分类量表1-2分为良好结局,3-5分为不良结局(含死亡)。

研究设计与关键结果

  • 研究类型:对232例院外心脏骤停患者检测入院时和第三天血浆补体激活产物C3bc、sC5b-9及可溶性CD14,并检测内皮激活标志物syndecan-1、sE-selectin、血栓调节蛋白和血管细胞黏附分子,6个月时评估脑功能分类结局。
  • 49%的患者6个月时结局良好;入院时C3bc和sC5b-9显著高于第三天(两者p<0.001),且不良结局组显著高于良好结局组(p=0.03和p<0.001)。
  • 未校正时入院sC5b-9与不良结局相关(OR 1.08,95%CI 1.01-1.14,p=0.024);校正后sC5b-9仍与结局相关,但将自主循环恢复时间>25分钟作为协变量纳入后关联不再显著。
  • 内皮细胞激活标志物从入院到第三天升高,仅sE-selectin和血栓调节蛋白在不良结局组显著高于良好结局组(p=0.004和p=0.03),sE-selectin与sCD14相关,血栓调节蛋白与sC5b-9/C3bc相关。

证据类型、等级与局限

  • 证据类型:观察性研究(对232例院外心脏骤停患者的血浆标志物与6个月结局分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为入院时sC5b-9反映的补体系统激活并导致后续内皮细胞激活,与院外心脏骤停患者不良结局相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Cardiopulmonary resuscitation after cardiac arrest initiates a whole-body ischemia-reperfusion injury, which may activate the innate immune system, including the complement system. We hypothesized that complement activation and subsequent release of soluble endothelial activation markers were associated with cerebral outcome including death.

METHODS: Outcome was assessed at six months and defined by cerebral performance category scale (1-2; good outcome, 3-5; poor outcome including death) in 232 resuscitated out-of-hospital cardiac arrest patients. Plasma samples obtained at admission and day three were analysed for complement activation products C3bc, the soluble terminal complement complex (sC5b-9), and soluble CD14. Endothelial cell activation was measured by soluble markers syndecan-1, sE-selectin, thrombomodulin, and vascular cell adhesion molecule.

RESULTS: Forty-nine percent of the patients had good outcome. C3bc and sC5b-9 were significantly higher at admission compared to day three (p < 0.001 for both) and in patients with poor compared to good outcome (p = 0.03 and p < 0.001, respectively). Unadjusted, higher sC5b-9 at admission was associated with poor outcome (odds ratio 1.08 (95% CI 1.01-1.14), p = 0.024). Adjusted, sC5b-9 was still associated with outcome, but the association became non-significant when time to return-of-spontaneous-circulation above 25 min was included as a covariate. Endothelial cell activation markers increased from admission to day three, but only sE-selectin and thrombomodulin were significantly higher in patients with poor versus good outcome (p = 0.004 and p = 0.03, respectively) and correlated to sCD14 and sC5b-9/C3bc, respectively.

CONCLUSION: Complement system activation, reflected by sC5b-9 at admission, leading to subsequent endothelial cell activation, was associated with poor outcome in out-of-hospital cardiac arrest patients.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Chaban V, Nakstad ER, Stær-Jensen H, et al. Complement activation is associated with poor outcome after out-of-hospital cardiac arrest. Resuscitation. 2021. PMID: 34126135. doi:10.1016/j.resuscitation.2021.05.038

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。